Stefania Petrosino

13.1k total citations · 2 hit papers
113 papers, 10.7k citations indexed

About

Stefania Petrosino is a scholar working on Pharmacology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stefania Petrosino has authored 113 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Pharmacology, 31 papers in Physiology and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stefania Petrosino's work include Cannabis and Cannabinoid Research (103 papers), Diet, Metabolism, and Disease (26 papers) and Neuroscience and Neuropharmacology Research (16 papers). Stefania Petrosino is often cited by papers focused on Cannabis and Cannabinoid Research (103 papers), Diet, Metabolism, and Disease (26 papers) and Neuroscience and Neuropharmacology Research (16 papers). Stefania Petrosino collaborates with scholars based in Italy, United States and Canada. Stefania Petrosino's co-authors include Vincenzo Di Marzo, Tiziana Bisogno, Isabel Matias, Luciano De Petrocellis, Aniello Schiano Moriello, Pierangelo Orlando, Alessia Ligresti, Marco Allarà, Teresa Iuvone and Angelo A. Izzo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Stefania Petrosino

113 papers receiving 10.5k citations

Hit Papers

Effects of cannabinoids and cannabinoid‐enriched Cannabis... 2006 2026 2012 2019 2010 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Petrosino Italy 63 7.8k 3.0k 2.3k 1.9k 1.5k 113 10.7k
Isabel Matias France 43 5.8k 0.7× 2.1k 0.7× 1.8k 0.8× 2.0k 1.1× 1.0k 0.7× 75 7.7k
Filomena Fezza Italy 43 6.1k 0.8× 3.0k 1.0× 1.3k 0.6× 1.2k 0.7× 1.0k 0.7× 80 7.8k
Ruth A. Ross United Kingdom 45 7.9k 1.0× 4.5k 1.5× 1.1k 0.5× 1.0k 0.6× 2.0k 1.3× 111 9.8k
Claire Williams United Kingdom 53 3.6k 0.5× 2.3k 0.8× 1.6k 0.7× 1.1k 0.6× 1.2k 0.8× 195 9.1k
Aron H. Lichtman United States 68 12.3k 1.6× 7.2k 2.4× 2.4k 1.0× 1.3k 0.7× 2.5k 1.7× 240 15.4k
Silvana Gaetani Italy 38 3.8k 0.5× 1.8k 0.6× 1.5k 0.7× 1.1k 0.6× 1.6k 1.1× 80 6.9k
Andreas Zimmer Germany 72 8.2k 1.0× 6.4k 2.2× 3.0k 1.3× 1.4k 0.8× 4.8k 3.3× 222 16.5k
Judith Harvey‐White United States 38 4.1k 0.5× 1.8k 0.6× 1.6k 0.7× 1.9k 1.0× 1.2k 0.8× 66 7.3k
Fabiana Piscitelli Italy 47 4.1k 0.5× 1.4k 0.5× 1.9k 0.8× 1.1k 0.6× 1.2k 0.8× 170 7.0k
Aviva Breuer Israel 28 7.0k 0.9× 3.5k 1.2× 729 0.3× 867 0.5× 907 0.6× 38 7.9k

Countries citing papers authored by Stefania Petrosino

Since Specialization
Citations

This map shows the geographic impact of Stefania Petrosino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Petrosino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Petrosino more than expected).

Fields of papers citing papers by Stefania Petrosino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Petrosino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Petrosino. The network helps show where Stefania Petrosino may publish in the future.

Co-authorship network of co-authors of Stefania Petrosino

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Petrosino. A scholar is included among the top collaborators of Stefania Petrosino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Petrosino. Stefania Petrosino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moriello, Aniello Schiano, Fiorentina Roviezzo, Fabio Arturo Iannotti, et al.. (2022). First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury. Biomolecules. 13(1). 33–33. 5 indexed citations
2.
Manzo, Emiliano, Aniello Schiano Moriello, Roberta Verde, et al.. (2021). A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator. Cells. 10(2). 450–450. 4 indexed citations
3.
Mugnaini, Claudia, Antonella Brizzi, Stefania Petrosino, et al.. (2018). Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease. European Journal of Medicinal Chemistry. 161. 239–251. 29 indexed citations
4.
Petrosino, Stefania, Marika Cordaro, Roberta Verde, et al.. (2018). Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. Frontiers in Pharmacology. 9. 249–249. 72 indexed citations
5.
Petrosino, Stefania, et al.. (2018). Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. Journal of Pharmacology and Experimental Therapeutics. 365(3). 652–663. 130 indexed citations
6.
Cremon, Cesare, Vincenzo Stanghellini, Maria Raffaella Barbaro, et al.. (2017). Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 45(7). 909–922. 100 indexed citations
7.
Cristino, Luigia, Giuseppe Busetto, Roberta Imperatore, et al.. (2013). Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proceedings of the National Academy of Sciences. 110(24). E2229–38. 123 indexed citations
8.
Scuderi, Caterina, Giuseppe Esposito, Angelo Blasio, et al.. (2011). Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide. Journal of Cellular and Molecular Medicine. 15(12). 2664–2674. 89 indexed citations
9.
Cerrato, Santiago Grau, Pilar Brazís, Maria Federica della Valle, et al.. (2011). Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs. The Veterinary Journal. 191(3). 377–382. 28 indexed citations
10.
Giordano, Catia, Luigia Cristino, Livio Luongo, et al.. (2011). TRPV1-Dependent and -Independent Alterations in the Limbic Cortex of Neuropathic Mice: Impact on Glial Caspases and Pain Perception. Cerebral Cortex. 22(11). 2495–2518. 87 indexed citations
11.
Petrosino, Stefania & Vincenzo Di Marzo. (2010). FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.. PubMed. 11(1). 51–62. 162 indexed citations
12.
Guidali, C., Daniela Viganò, Stefania Petrosino, et al.. (2010). Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. The International Journal of Neuropsychopharmacology. 14(1). 17–28. 41 indexed citations
13.
Petrosino, Stefania & Vincenzo Di Marzo. (2009). Anandamide and Other Acylethanolamides. 75–98. 2 indexed citations
14.
Marzo, Vincenzo Di, An Verrijken, Antti Hakkarainen, et al.. (2009). Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. European Journal of Endocrinology. 161(5). 715–722. 97 indexed citations
15.
Bordicchia, Marica, Lucia Mancinelli, Elena Giannini, et al.. (2009). Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. Metabolism. 59(5). 734–741. 43 indexed citations
16.
Iuvone, Teresa, Giuseppe Esposito, Daniele De Filippis, et al.. (2007). Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. Journal of Molecular Medicine. 85(12). 1379–1392. 37 indexed citations
17.
Izzo, Angelo A., Gabriella Aviello, Stefania Petrosino, et al.. (2007). Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. Journal of Molecular Medicine. 86(1). 89–98. 95 indexed citations
18.
Matias, Isabel, Stefania Petrosino, Ludovico Docimo, et al.. (2007). Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells. British Journal of Pharmacology. 152(5). 676–690. 92 indexed citations
19.
Petrosino, Stefania, Enza Palazzo, Vito de Novellis, et al.. (2006). Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology. 52(2). 415–422. 196 indexed citations
20.
Stelt, Mario van der, Susan H. Fox, Michael P. Hill, et al.. (2005). A role for endocannabinoids in the generation of parkinsonism and levodopa‐induced dyskinesia in MPTP‐lesioned non‐human primate models of Parkinson's disease. The FASEB Journal. 19(9). 1140–1142. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026